Article ID Journal Published Year Pages File Type
10612843 Journal of Controlled Release 2013 8 Pages PDF
Abstract
A fusion of glucagon-like peptide-1 and elastin-like polypeptide is able to reduce blood glucose for over 5 days after a single injection by forming an extended release subcutaneous depot and prolonging peptide circulation time.99
Keywords
Related Topics
Physical Sciences and Engineering Materials Science Biomaterials
Preview
A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection
Authors
, , , , ,